NCT02765555View on ClinicalTrials.gov

First in Man Study of Safety, Tolerability and PK Profile of RBP-7000

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Schizophrenia

Interventions

DRUG

RBP-7000

Single dose

Trial Locations (1)

08046

CRI Worldwide, Willingboro

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Indivior Inc.

INDUSTRY